AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Nextage Therapeutics Ltd.

Regulatory News Service • Sep 28, 2025

6946_rns_2025-09-28_5e544642-a258-4a87-a6b7-ebe2af23455b.pdf

Regulatory News Service

Open in Viewer

Opens in native device viewer

September 28, 2025 460476

To: TASE Members

Dear Sir/Madam,

Re: Suspension of trade due to failure in publishing financial reports-Notification

In accordance with the provisions of the forth Part of TASE's rules, TASE's CEO, or someone authorized by him, shall suspend trade in a security in the event that the company has not submitted financial statements and one month has passed from the date stipulated for their submission in the periodic report regulations.

Below is a list of the companies which have not yet submitted there financial statements as of June 30, 2025:

NEXTGEN BIOMED LTD NEXTAGE THERAPEUTICS LTD ISRAEL AEROSPACE INDUSTRIES LTD

Trading in the companies' securities will be suspended on October 5, 2025, unless the companies will publish their financial statemetnts by this date.

Sincerely

)-(

Listing companies compliance unit

Talk to a Data Expert

Have a question? We'll get back to you promptly.